HY-W181102-100mg
|
MedChemexpress LLC
|
NFAT Inhibitor-2 [CAS 422546-87-0]
|
|
COVID-19-immunoregulation
|
|
HY-W181102-50mg
|
MedChemexpress LLC
|
NFAT Inhibitor-2 [CAS 422546-87-0]
|
|
COVID-19-immunoregulation
|
|
HY-W181102-1mL
|
MedChemexpress LLC
|
NFAT Inhibitor-2 [CAS 422546-87-0] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-P1309A-1mg
|
MedChemexpress LLC
|
PAR-4 Agonist Peptide, amide (TFA) [CAS 1228078-65-6]
|
|
COVID-19-immunoregulation
|
|
HY-P1309A-10mg
|
MedChemexpress LLC
|
PAR-4 Agonist Peptide, amide (TFA) [CAS 1228078-65-6]
|
|
COVID-19-immunoregulation
|
|
HY-P1309A-5mg
|
MedChemexpress LLC
|
PAR-4 Agonist Peptide, amide (TFA) [CAS 1228078-65-6]
|
|
COVID-19-immunoregulation
|
|
HY-P1309-1mg
|
MedChemexpress LLC
|
PAR-4 Agonist Peptide, amide [CAS 352017-71-1]
|
|
COVID-19-immunoregulation
|
|
HY-P1309-10mg
|
MedChemexpress LLC
|
PAR-4 Agonist Peptide, amide [CAS 352017-71-1]
|
|
COVID-19-immunoregulation
|
|
HY-P1309-5mg
|
MedChemexpress LLC
|
PAR-4 Agonist Peptide, amide [CAS 352017-71-1]
|
|
COVID-19-immunoregulation
|
|
HY-147297-10mg
|
MedChemexpress LLC
|
Pelecopan [CAS 2378380-49-3]
|
|
COVID-19-immunoregulation
|
|
HY-147297-100mg
|
MedChemexpress LLC
|
Pelecopan [CAS 2378380-49-3]
|
|
COVID-19-immunoregulation
|
|
HY-147297-25mg
|
MedChemexpress LLC
|
Pelecopan [CAS 2378380-49-3]
|
|
COVID-19-immunoregulation
|
|
HY-147297-5mg
|
MedChemexpress LLC
|
Pelecopan [CAS 2378380-49-3]
|
|
COVID-19-immunoregulation
|
|
HY-147297-50mg
|
MedChemexpress LLC
|
Pelecopan [CAS 2378380-49-3]
|
|
COVID-19-immunoregulation
|
|
HY-B0537B-100mg
|
MedChemexpress LLC
|
Pentamidine (isethionate) [CAS 140-64-7]
|
|
COVID-19-immunoregulation
|
|
HY-B0537B-50mg
|
MedChemexpress LLC
|
Pentamidine (isethionate) [CAS 140-64-7]
|
|
COVID-19-immunoregulation
|
|
HY-B0537B-1mL
|
MedChemexpress LLC
|
Pentamidine (isethionate) [CAS 140-64-7] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-109041-1mg
|
MedChemexpress LLC
|
Razuprotafib [CAS 1008510-37-9]
|
|
COVID-19-immunoregulation
|
|
HY-109041-10mg
|
MedChemexpress LLC
|
Razuprotafib [CAS 1008510-37-9]
|
|
COVID-19-immunoregulation
|
|
HY-109041-25mg
|
MedChemexpress LLC
|
Razuprotafib [CAS 1008510-37-9]
|
|
COVID-19-immunoregulation
|
|
HY-109041-5mg
|
MedChemexpress LLC
|
Razuprotafib [CAS 1008510-37-9]
|
|
COVID-19-immunoregulation
|
|
HY-109041-50mg
|
MedChemexpress LLC
|
Razuprotafib [CAS 1008510-37-9]
|
|
COVID-19-immunoregulation
|
|
HY-109041-1mL
|
MedChemexpress LLC
|
Razuprotafib [CAS 1008510-37-9] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-124756-1mg
|
MedChemexpress LLC
|
SBI-425 [CAS 1451272-71-1]
|
|
COVID-19-immunoregulation
|
|
HY-124756-10mg
|
MedChemexpress LLC
|
SBI-425 [CAS 1451272-71-1]
|
|
COVID-19-immunoregulation
|
|